Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of NC410 in advanced or metastatic solid tumors has been terminated, with results posted in 2024, in…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b [Phase 1]
First-in-human dose expansion Phase 1 trial of XMT-1536 targeting NaPi2b in cancers likely to express the transporter, including platinum-re…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating COM701 in combination with BMS-986207 and nivolumab in adults with advanced solid tumors, including e…
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer [Phase 2]
An update on a Phase 2 study evaluating a pan-immunotherapy in patients with relapsed/refractory ovarian cancer; the trial status is complet…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer [Phase 1]
This Phase 1 trial update reports completion of a study evaluating weekly paclitaxel with oncothermia and weekly cisplatin with oncothermia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: HRD Status Reference Standard Based on WGS
This clinical trial completed evaluation of an HRD status reference standard based on whole-genome sequencing for ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates adding anlotinib to standard carboplatin/paclitaxel chemotherapy as first-line therapy for advanced ovari…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]
A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage …
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neo-adjuvant pembrolizumab in primary stage IV ovarian cancer with peritoneal or fallopian tube involvement. The …
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies [Phase 1]
Phase 1 study evaluating safety and tolerability of immunotherapy combinations in triple-negative breast cancer and ovarian cancer has compl…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer [NA]
A completed clinical trial evaluated the efficacy and safety of stereotactic body radiotherapy (SBRT) in patients with oligo-metastatic/pers…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: 4FMFES-PET Imaging of Endometrial and Ovarian Cancers [Phase 1, Phase 2]
Clinical trial update announcing the completion of a Phase 1/Phase 2 study evaluating 4FMFES-PET imaging for Endometrial cancer and Ovarian …
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
This ongoing clinical trial investigates the use of circulating tumor DNA as a biomarker to improve the diagnosis of ovarian cancer and is c…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer [NA]
The LCC-CARIS-01 trial focusing on molecular profiling in gynecologic cancers has completed. The study included epithelial ovarian cancer, p…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: (GI-RADS) in Preoperative Evaluation of Adnexal Masses
A completed clinical trial evaluating GI-RADS for preoperative evaluation of adnexal masses in ovarian cancer, reporting diagnostic performa…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating 89Zr-MMOT PET imaging in pancreatic and ovarian cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study of DeTIL-0255 in Adults With Advanced Malignancies [Phase 1]
Phase 1 study of DeTIL-0255 in adults with advanced cancers (ovarian, endometrial, and cervical cancer) sponsored by Nurix Therapeutics has …
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
This clinical trial update reports that the study evaluating systematic lymphadenectomy during interval debulking surgery for advanced epith…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer [Phase 1]
The Phase 1 study of KHK2866, an HB-EGF–targeting antibody, in advanced solid tumors and ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in participants with recurrent ovarian, fallopian tube, or primary peritoneal carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase Ib/II clinical study evaluating HRS-1167 in combination with bevacizumab for recurrent ovarian cancer.